Overview
What is International Myeloma Foundation?
The International Myeloma Foundation (IMF) is a California-based nonprofit organization with a mission to lead collaborative myeloma research globally. Since 1995, they have funded over 151 grants for top research scientists, and their International Myeloma Working Group brings together experts to publish groundbreaking research, mentor future investigators, and improve care for myeloma patients. The Black Swan Research Initiative is a consortium of leading myeloma experts utilizing advanced technologies and treatments to develop new curative therapies. IMF is dedicated to enhancing the lives of myeloma patients, pursuing prevention and a cure. With a team of 43 employees, their work drives progress towards a myeloma-free future.
Official website here: www.myeloma.org
Is International Myeloma Foundation legitimate?
International Myeloma Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. International Myeloma Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $1,065,367
Professional Fundraising Fees: $0
Other Salaries and Wages: $6,601,162
For more financial information, click here
Official website here: www.myeloma.org
What is the mission statement of International Myeloma Foundation?
The International Myeloma Foundation is committed to enhancing the lives of myeloma patients as they strive towards finding prevention and a cure. The organization is at the forefront of collaborative myeloma research, funding over 151 grants for esteemed research scientists since 1995. They bring together leading experts in the field through the International Myeloma Working Group, driving groundbreaking research and shaping the path to a cure. The Black Swan Research Initiative, a consortium of top myeloma experts, is harnessing new technologies and innovative treatments to discover cure pathways. The Black Swan Research Strategy focuses on making the most of novel therapies and ultra-sensitive tests to monitor therapy progression in patients. The International Myeloma Foundation is dedicated to developing new curative therapies for myeloma.
Official website here: www.myeloma.org
Who is the CEO of International Myeloma Foundation?
Yelak Biru is the Director of International Myeloma Foundation. The CEO's salary of International Myeloma Foundation is $203,321 and their total compensation is $203,348.
Official website here: www.myeloma.org
What is the revenue of International Myeloma Foundation?
International Myeloma Foundation's revenue in 2022 was $18,062,675.
Official website here: www.myeloma.org
Who are the executives of International Myeloma Foundation and what are their salaries?
The average compensation at International Myeloma Foundation during 2022 was $178,291. There are 43 employees at International Myeloma Foundation.
Here are 23 key members and their salaries (International Myeloma Foundation's CEO's salary is $203,321 and their total compensation is $203,348):
- Diane Moran (Strategic Planner)
- Joseph Mikhael (Chief Medical Officer)
- Jennifer Scarne (Chief Financial Officer)
- Susan Durie (Director)
- Lisa Paik (Senior Vice President)
- Lynn Green (Senior Vice President, Phi)
- Yelak Biru (Ceo, President) [Trustee/Director]
- Andrew Kuzneski Iii (Director)
- Benson Klein (Director)
- Charles Newman (Director)
- Christine Battistini (Director)
- Dr Brian Durie (Director)
- Dr Edith Mitchell (Director)
- Dr Heinz Ludwig (Director)
- Dr Mario Boccadoro (Director)
- Dr Robert A Kyle (Director)
- Dr Vincent Rajkumar (Director)
- E Michael D Scott (Director)
- George T Hayum (Director)
- Jason Katz (Director)
- Loraine Boyle (Director)
- Martine Elias (Director)
- Matthew Robinson (Director)
Official website here: www.myeloma.org
Where can I find the form 990 for International Myeloma Foundation?
The International Myeloma Foundation’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.myeloma.org
Learn more at the official website: www.myeloma.org
Mission Statement of International Myeloma Foundation
The International Myeloma Foundation (IMF) is a leading organization dedicated to enhancing the quality of life of myeloma patients and relentlessly pursuing prevention and a cure. With a focus on collaborative myeloma research, IMF has awarded over 151 research grants to distinguished scientists since its inception in 1995. The organization brings together the world's foremost myeloma experts through the International Myeloma Working Group. Together, they publish groundbreaking research in prestigious medical journals, chart the course to a cure, mentor the next generation of innovative investigators, and improve lives through better care.
Moreover, IMF's Black Swan Research Initiative is a multinational consortium of leading myeloma experts harnessing new technologies and the latest myeloma treatments to discover a pathway to a cure. This research strategy capitalizes on the availability of potent novel therapies and the advent of ultra-sensitive tests to measure precisely when and how those therapies are effective in patients. The Black Swan Research Initiative is fully committed to developing new curative therapies for myeloma. The International Myeloma Foundation's unwavering dedication, collaboration, and innovative spirit have made significant strides in the quest for a myeloma cure.
Impact
This information is meant to be a general summary of International Myeloma Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
International Myeloma Foundation's impact is profound in the field of myeloma research and patient care. Through its globally collaborative research efforts, IMF has provided funding for over 151 grants to top junior and senior research scientists since 1995. The organization plays a crucial role in bringing together leading experts in innovative ways through the International Myeloma Working Group, which is paving the way towards a cure for myeloma.
Additionally, IMF's Black Swan Research Initiative, a multinational consortium of myeloma experts, is at the forefront of harnessing new technologies and treatments to develop curative therapies for myeloma patients. By capitalizing on novel therapies and sensitive tests, this initiative aims to improve the lives of myeloma patients by advancing the understanding and treatment of this disease.
Overall, the International Myeloma Foundation's dedication to improving the quality of life for myeloma patients while striving for prevention and a cure has made a significant impact on the myeloma community and the field of myeloma research worldwide.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
SUPPORT GROUP
Revenue
$6,770
Organization Details
Founding Year
1990
Phone
(818) 487-7455
Principal Officer
Yelak Biru
Main Address
4400 COLDWATER CANYON AVE 300, STUDIO CITY, CA, 91604
Website
www.myeloma.org
NTEE Category
Code: Z99Z - Unknown
If you are a representative of International Myeloma Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.